Screener
Idexx Laboratories IDXX Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Idexx Laboratories’s reported figures.
Based on trailing twelve months.
The source filing: Idexx Laboratories’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:14 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874716-26-000076
FAQ
- What is Idexx Laboratories's return on equity?
- Idexx Laboratories (IDXX) reported return on equity of 72.9% in Q1 2026.
- How has Idexx Laboratories's return on equity changed year-over-year?
- Idexx Laboratories's return on equity increased by 22.9% year-over-year, from 59.3% to 72.9%.
- What is the long-term trend for Idexx Laboratories's return on equity?
- Over 5 years (2020 to 2025), Idexx Laboratories's return on equity has grown at a -14.4% compound annual growth rate (CAGR), from 143.7% to 66.2%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Idexx Laboratories's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude